为儿科患者提供临时配方:全球需求,挑战和机遇
Vinita Balakrishna Pai1, Milap Chand Nahata1,2
1Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
Pharmaceutics
|January 28, 2026
概括
当商业药物不适合时,即兴的复合会为儿童创造个性化的药物剂量. 解决数据缺口和法规等障碍对于推进儿科药物治疗至关重要.
科学领域:
- 制药科学 制药科学
- 儿科药理学 儿科药理学
- 药物复杂化药物复杂化
背景情况:
- 商业药物往往缺乏适合儿科患者的适当剂量形式.
- 当需要时,即时复合提供了个性化的剂量和配方.
- 复合解决了诸如吞困难,无法获得的度和不安全的辅助剂等挑战.
研究的目的:
- 审查儿科药物治疗中即兴复合的现状.
- 突出复合制剂的必要性,挑战和解决方案.
- 检查框架,主要来自美国,用于临时复合实践.
主要方法:
- 文献评论专注于即兴复合实践和挑战.
- 对无菌和非无菌化合物的药典标准的分析.
- 对复合制剂的稳定性数据的检查和使用后的日期考虑.
主要成果:
- 对儿科患者,特别是婴儿和儿童来说,即时复合非常重要.
- 重要障碍包括药物获取有限,专业知识缺口,数据不足和监管问题.
- 新兴的配方,如口溶膜和3D打印化合物,提供了机遇和挑战.
结论:
- 随机复合对于个性化儿科药物治疗至关重要.
- 解决已识别的障碍是改善复合药物的获取和安全的关键.
- 需要持续的研究和务实的解决方案来推进儿科药物配方.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
225
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Global Climate Change
28.9K
Throughout its ~4.5 billion year history, the Earth has experienced periods of warming and cooling. However, the current drastic increase in global temperatures is well outside of the Earth’s cyclic norms, and evidence for human-caused global climate change is compelling. Paleoclimatology, the study of ancient climate conditions, provides ample evidence for human-caused global climate change by comparing recent conditions with those in the past.
28.9K
Pharmacokinetics in Pediatric Patients: Drug Distribution
285
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism
213
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
213
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
272
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
272
Introduction to Global Positioning System
505
The Global Positioning System (GPS) revolutionized positioning on Earth, providing precise location data through satellite ranging. The GPS system was developed in 1978 by the U.S. Department of Defense for military use, and it became available for civilian applications in 1983, transforming fields including navigation, fleet management, and time synchronization for telecommunications systems.GPS consists of satellites in medium Earth orbit, about 20,200 kilometers above the surface,...
505


